Search Results

Return to List
Results 41–60 of 104
Title Date
41.

Elder Abuse and Women's Health

Number 568

ABSTRACT Elder abuse a violation of human rights is defined as a single or repeated act or lack of appropriate actions which causes harm risk of harm or distress to an individual 60 years or older As many as 1 in 10 older adults have been victims of elder abuse Most cases of abuse occur in women T...

July 2013

PDF Format
42.

Professional Liability and Gynecology-Only Practice

Number 567

(Replaces No. 408, June 2008)

ABSTRACT Fellows of the American College of Obstetricians and Gynecologists may choose to limit the scope of their practices to gynecology and accordingly may choose not to carry professional liability coverage for obstetrics The American College of Obstetricians and Gynecologists considers early ...

July 2013

PDF Format
43.

Hormone Therapy and Heart Disease

Number 565

(Replaces No. 420, November 2008)

ABSTRACT Menopausal hormone therapy should not be used for the primary or secondary prevention of coronary heart disease at the present time Evidence is insufficient to conclude that longterm estrogen therapy or hormone therapy use improves cardiovascular outcomes Nevertheless recent evidence sugg...

June 2013

PDF Format
44.

Ethical Issues With Vaccination for the Obstetrician–Gynecologist

Number 564

ABSTRACT Because of the growing importance of infectious disease prevention in the individual patient and the larger community it is vital that Fellows of the American College of Obstetricians and Gynecologists be prepared to navigate the practical and ethical challenges that come with vaccination...

May 2013

PDF Format
45.

Müllerian Agenesis: Diagnosis, Management, and Treatment

Number 562

(Replaces No. 355, December 2006, Reaffirmed 2015)

ABSTRACT Müllerian agenesis occurs in 1 out of every 400010000 females The most common presentation of müllerian agenesis is congenital absence of the vagina uterus or both which also is referred to as müllerian aplasia MayerRokitanskyKüsterHauser syndrome or vaginal agenesis Satisfactory vaginal ...

May 2013

PDF Format
46.

Integrating Immunizations Into Practice

Number 558

(Reaffirmed 2015)

ABSTRACT Given demonstrated vaccine efficacy safety and the large potential for prevention of many infectious diseases among adults newborns and pregnant women obstetriciangynecologists should embrace immunizations as an integral part of their womens health care practice To provide direct examples...

April 2013

PDF Format
47.

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women

Number 557

(Reaffirmed 2015)

ABSTRACT Initial evaluation of the patient with acute abnormal uterine bleeding should include a prompt assessment for signs of hypovolemia and potential hemodynamic instability After initial assessment and stabilization the etiologies of acute abnormal uterine bleeding should be classified using ...

April 2013

PDF Format
48.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Number 556

(Reaffirmed 2015)

ABSTRACT The development of menopausal symptoms and related disorders which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy is a common reason for a patient to visit her gynecologist but these therapies are associated with an increased risk of venous thromb...

April 2013

PDF Format
49.

Reproductive and Sexual Coercion

Number 554

ABSTRACT Reproductive and sexual coercion involves behavior intended to maintain power and control in a relationship related to reproductive health by someone who is was or wishes to be involved in an intimate or dating relationship with an adult or adolescent This behavior includes explicit attem...

February 2013

PDF Format
50.

Multifetal Pregnancy Reduction

Number 553

(Replaces Committee Opinion Number 369, June 2007)

ABSTRACT Fertility treatments have contributed significantly to the increase in multifetal pregnancies The first approach to the problem of multifetal pregnancies should be prevention and strategies to limit multifetal pregnancies especially highorder multifetal pregnancies should be practiced by ...

February 2013

PDF Format
51.

Benefits to Women of Medicaid Expansion Through the Affordable Care Act

Number 552

ABSTRACT Many US women are uninsured and face avoidable adverse obstetric and gynecologic health outcomes The Affordable Care Act requires an expansion of Medicaid that would increase the percentage of US women with health insurance with the anticipated benefit of improved health The 2012 Supreme ...

January 2013

PDF Format
52.

Health Care for Women in the Military and Women Veterans

Number 547

Abstract Military service is associated with unique risks to womens reproductive health As increasing numbers of women are serving in the military and a greater proportion of United States Veterans are women it is essential that obstetriciangynecologists are aware of and well prepared to address t...

December 2012

PDF Format
53.

Over-the-Counter Access to Oral Contraceptives

Number 544

(Reaffirmed 2014)

ABSTRACT Unintended pregnancy remains a major public health problem in the United States Access and cost issues are common reasons why women either do not use contraception or have gaps in use A potential way to improve contraceptive access and use and possibly decrease unintended pregnancy rates ...

December 2012

PDF Format
54.

Access to Emergency Contraception

Number 542

ABSTRACT Emergency contraception includes contraceptive methods used to prevent pregnancy in the first few days after unprotected intercourse sexual assault or contraceptive failure Although the US Food and Drug Administration approved the first dedicated product for emergency contraception in 199...

November 2012

PDF Format
55.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

(Reaffirmed 2014)

ABSTRACT Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones and some data have suggested that use of drospirenonecontaining pills has a higher risk of venous thromboembolism this risk is still ...

November 2012

PDF Format
56.

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Number 539

(Replaces Committee Opinion No. 392, December 2007, Reaffirmed 2014)

ABSTRACT Longacting reversible contraception LARCintrauterine devices and the contraceptive implantare safe and appropriate contraceptive methods for most women and adolescents The LARC methods are toptier contraceptives based on effectiveness with pregnancy rates of less than 1 per year for perfe...

October 2012

PDF Format
57.

Reprocessed Single-Use Devices

Number 537

(Reaffirmed 2014)

ABSTRACT The reprocessing and reuse of singleuse instruments has become increasingly common Although there are limited data on reprocessed singleuse devices existing studies have found a significant rate of physical defects performance issues or improper decontamination There are currently no data...

October 2012

PDF Format
58.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the US correctional system Incarcerated women and adolescent females often come from disadvantaged environments and have high rates ...

August 2012

PDF Format
59.

Well-Woman Visit

Number 534

(Reaffirmed 2014)

Abstract The annual health assessment annual examination is a fundamental part of medical care and is valuable in promoting prevention practices recognizing risk factors for disease identifying medical problems and establishing the clinicianpatient relationship The annual health assessment should ...

August 2012

PDF Format
60.

Compounded Bioidentical Menopausal Hormone Therapy

Number 532

(Reaffirmed 2014, Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT Although improvement in longterm health is no longer an indication for menopausal hormone therapy evidence supporting fewer adverse events in younger women combined with its high overall effectiveness has reinforced its usefulness for shortterm treatment of menopausal symptoms Menopausal ...

August 2012

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998